LOXO-101 sulfate

The sulfate salt form of LOXO-101, also called Larotrectinib, which is an ATP-competitive inhibitor of tropomyosin receptor kinases. It was approved by FDA for the treatment of metastatic solid tumors.
Supplier BOC Sciences
Product # B0084-474404
Pricing Inquire
Cas 1223405-08-0
Molecular Weight 526.51
Molecular Formula C21H24F2N6O6S
Canonical SMILES C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F.OS(=O)(=O)O
Feedback